EYENOVIA INC. - COMMON STOCK

Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference

21 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming H.C. Wainwright 25th Annual Global Investment Conference

07 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Announces $12 Million Registered Direct Offering

24 8 2023 17:47:29 提供 Nasdaq GlobeNewswire

Eyenovia Acquires U.S. Commercial Rights to APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension, 0.05%) from Formosa Pharmaceuticals

16 8 2023 05:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update

10 8 2023 15:05:01 提供 Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference

09 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia to Report Second Quarter 2023 Results on Thursday, August 10

07 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

Eyenovia Announces First Commercial Sale of Mydcombi™

03 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

Eyenovia Announces Addition to Russell 2000® and Russell 3000® Indexes

26 6 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Announces Presentation at the OCTANE Ophthalmology Tech Forum 2023

01 6 2023 07:00:01 提供 Nasdaq GlobeNewswire

Eyenovia Reports First Quarter 2023 Financial Results and Provides Business Update

11 5 2023 15:05:01 提供 Nasdaq GlobeNewswire

Eyenovia Announces FDA Approval of Mydcombi™, the First Ophthalmic Spray for Mydriasis, Which Also Leverages the Company’s Proprietary Optejet® Device Platform

08 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia to Report First Quarter 2023 Results on Thursday, May 11

04 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Announces Poster Presentation at ARVO 2023

24 4 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Reports Fourth Quarter 2022 Financial Results and Provides Business Update

30 3 2023 15:05:01 提供 Nasdaq GlobeNewswire

Eyenovia to Report Fourth Quarter and Full-Year 2022 Results on Thursday, March 30

23 3 2023 07:00:01 提供 Nasdaq GlobeNewswire

Eyenovia Announces Independent Director Stephen Benjamin to Step Down to Assume Role of Head of White House’s Office of Public Engagement

28 2 2023 15:05:01 提供 Nasdaq GlobeNewswire

Eyenovia Announces Development Collaboration Agreement with Formosa Pharmaceuticals

15 2 2023 08:51:05 提供 Nasdaq GlobeNewswire

Eyenovia Reveals Positive Evidence That Optejet® Delivery Technology Decreased Inflammation From Preserved Glaucoma Solutions Compared to Drops

12 1 2023 07:00:00 提供 Nasdaq GlobeNewswire

Eyenovia Announces Participation at the 2023 International Consumer Electronics Show

20 12 2022 07:00:00 提供 Nasdaq GlobeNewswire